End-of-day quote
Korea S.E.
18:00:00 2024-06-03 EDT
5-day change
1st Jan Change
55,300
KRW
-7.83%
-11.52%
+38.25%
T&L Co., Ltd.'s Equity Buyback announced on June 15, 2022, has expired with 55,989 shares, representing 0.69% for KRW 1,878.89 million.
The company expired its plan on June 13, 2023.
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.
23-06-13
CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.
23-06-13
CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.
23-06-13
CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.
23-06-13
CI
Tranche Update on T&L Co., Ltd.'s Equity Buyback Plan announced on June 15, 2022.
23-06-13
CI
T&L Co., Ltd.'s Equity Buyback announced on June 15, 2022, has expired with 55,989 shares, representing 0.69% for KRW 1,878.89 million.
23-06-12
CI
T&L Co., Ltd.'s Equity Buyback Plan Extended till June 13, 2023.
22-12-12
CI
T&L Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.
22-06-14
CI
T&L Co., Ltd. authorizes a Buyback Plan.
22-06-14
CI
T&L Co., Ltd.(KOSDAQ:A340570) added to S&P Global BMI Index
21-09-20
CI
1,388,000 Common Stock of T&L Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JUN-2021.
21-06-19
CI
24,000 Common Stock of T&L Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-MAR-2021.
21-03-19
CI
T&L Co., Ltd. has completed an IPO in the amount of KRW 28.8 billion.
20-11-16
CI
T&L Co., Ltd. has filed an IPO.
20-04-28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
More about the company
Last Close Price
55,300
KRW
Average target price
71,500
KRW
Spread / Average Target
+29.29%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1